Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Oncology
Volume 35, Supplement 3 (June 2008)
Search Within This Issue
A New Microtubule Targeting Agent (MTA): Vinflunine. From Discovery to Patient Treatment
Edited by Susan Band Horowitz MD
Pierre Fabre

display abstract citation download email a colleague
Display:


Masthead
page IFC
Full-Text PDF (43 KB)


Introduction
Susan Band Horwitz
pages S1-S2
Full Text | Full-Text PDF (44 KB)


Vinflunine: Discovery and Synthesis of a Novel Microtubule Inhibitor
Jacques Fahy, Paul Hellier, Fabienne Breillout, Christian Bailly
pages S3-S5
Full Text | Full-Text PDF (301 KB)


Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor Vinflunine
Mary Ann Jordan, Susan Band Horwitz, Sharon Lobert, John J. Correia
pages S6-S12
Abstract | Full Text | Full-Text PDF (474 KB)


Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies
Diane Braguer, Jean-Marc Barret, Hayley McDaid, Anna Kruczynski
pages S13-S21
Abstract | Full Text | Full-Text PDF (1909 KB)


Potential Mechanisms of Resistance to Microtubule Inhibitors
Maria Kavallaris, Jean-Philippe Annereau, Jean-Marc Barret
pages S22-S27
Abstract | Full Text | Full-Text PDF (255 KB)


Pharmacokinetics, Metabolites, and Preclinical Safety of Vinflunine
Sharon Lobert, Christian Puozzo
pages S28-S33
Abstract | Full Text | Full-Text PDF (419 KB)


Clinical Activity of Vinflunine in Transitional Cell Carcinoma of the Urothelium and Other Solid Tumors
Joaquim Bellmunt, Francois-Michel Delgado, Claude George
pages S34-S43
Abstract | Full Text | Full-Text PDF (115 KB)

Frontmatter


Table of Contents
page A1
Full-Text PDF (32 KB)

display abstract citation download email a colleague
Display:
Advertisement